Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Elise Martel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Therapie|October 30, 2025
Artificial intelligence for precision medicineMarie-Elise Martel, Adan José-Garcia, Celine Vens, et al.
Rheumatology (Oxford, England)|July 17, 2025
Anti-RNA polymerase III antibodies in systemic sclerosis: prevalence and clinical associations from a systematic review and meta-analysisAbderrahmane Elhannani, Marie-Elise Martel, Aurore Collet, et al.
Autoimmunity Reviews|March 30, 2024
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysisMarie-Elise Martel, Amélie Leurs, David Launay, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Therapie|October 30, 2025
Artificial intelligence for precision medicineMarie-Elise Martel, Adan José-Garcia, Celine Vens, et al.
Rheumatology (Oxford, England)|July 17, 2025
Anti-RNA polymerase III antibodies in systemic sclerosis: prevalence and clinical associations from a systematic review and meta-analysisAbderrahmane Elhannani, Marie-Elise Martel, Aurore Collet, et al.
Autoimmunity Reviews|March 30, 2024
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysisMarie-Elise Martel, Amélie Leurs, David Launay, et al.
Pageof 1